Important role of mast cells in multiple sclerosis

被引:40
作者
Conti, P. [1 ]
Kempuraj, D. [2 ]
机构
[1] Univ G dAnnunzio, Sch Med, Viale Unite Italia 73, I-66013 Chieti, Italy
[2] Univ Iowa, Carver Coll Med, Dept Neurol, Iowa City, IA 52242 USA
关键词
Multiple sclerosis; Mast cells; Immunity; Inflammation; CORTICOTROPIN-RELEASING HORMONE; CENTRAL-NERVOUS-SYSTEM; T-CELLS; AUTOIMMUNE ENCEPHALOMYELITIS; CEREBROSPINAL-FLUID; INFLAMMATION; CYTOKINES; MYELIN; ACTIVATION; DISEASE;
D O I
10.1016/j.msard.2015.11.005
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Autoimmunity is a disease that occurs when the body tissue is attacked by its own immune system. Multiple sclerosis (MS) is an autoimmune illness which triggers neurological progressive and persistent functions. MS is associated with an abnormal B-cell response and upregulation of T-cell reactivity against a multitude of antigens. Mast cells are the first line of the innate immune system and act by de granulating and secreting chemical mediators and cytokines. Their participation on the central nervous system has been recognized since the beginning of the last century. They have an important role in autoimmune disease, including MS where they mediate inflammation and demyelinization by presenting myelin antigens to T cells or disrupting the blood-brain barrier and permitting entry of inflammatory cells and cytokines. The participation of mast cells in MS is demonstrated by gene overexpression of chemical mediators and inflammatory cytokines. Here we report the relationship and involvement between mast cells and multiple sclerosis. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:77 / 80
页数:4
相关论文
共 57 条
[1]   Serum and cerebrospinal fluid cytokine concentrations in subacute sclerosing panencephalitis [J].
Aydin, Oemer Faruk ;
Ichiyama, Takashi ;
Anlar, Banu .
BRAIN & DEVELOPMENT, 2010, 32 (06) :463-466
[2]   The Limited Contribution of Fyn and Gab2 to the High Affinity IgE Receptor Signaling in Mast Cells [J].
Barbu, Emilia Alina ;
Zhang, Juan ;
Siraganian, Reuben P. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (21) :15761-15768
[3]   Emerging concepts in autoimmune encephalomyelitis beyond the CD4/TH1 paradigm [J].
Batoulis, Helena ;
Addicks, Klaus ;
Kuerten, Stefanie .
ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER, 2010, 192 (04) :179-193
[4]   Update on Inflammation, Neurodegeneration, and Immunoregulation in Multiple Sclerosis: Therapeutic Implications [J].
Bennett, Jeffrey L. ;
Stuve, Olaf .
CLINICAL NEUROPHARMACOLOGY, 2009, 32 (03) :121-132
[5]  
Biddison WE, 1998, J IMMUNOL, V160, P444
[6]   Profile of cerebrospinal fluid and serum cytokines in patients with relapsing-remitting multiple sclerosis: A correlation with clinical activity. [J].
Carrieri, PB ;
Provitera, V ;
De Rosa, T ;
Tartaglia, G ;
Gorga, F ;
Perrella, O .
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 1998, 20 (03) :373-382
[7]   Modulation of autoimmunity by the latest interleukins (with special emphasis on IL-32) [J].
Conti, P. ;
Youinou, P. ;
Theoharides, T. C. .
AUTOIMMUNITY REVIEWS, 2007, 6 (03) :131-137
[8]   Impact of Rantes and MCP-1 chemokines on in vivo basophilic cell recruitment in rat skin injection model and their role in modifying the protein and mRNA levels for histidine decarboxylase [J].
Conti, P ;
Pang, XZ ;
Boucher, W ;
Letourneau, R ;
Reale, M ;
Barbacane, RC ;
Thibault, J ;
Theoharides, TC .
BLOOD, 1997, 89 (11) :4120-4127
[9]   The role of microglial activation in disease progression [J].
Correale, Jorge .
MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (10) :1288-1295
[10]   The impact of environmental infections (parasites) on MS activity [J].
Correale, Jorge ;
Farez, Mauricio F. .
MULTIPLE SCLEROSIS JOURNAL, 2011, 17 (10) :1162-1169